These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 20847676

  • 1. Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition.
    Chu HS, Hu FR, Yang CM, Yeh PT, Chen YM, Hou YC, Chen WL.
    Cornea; 2011 Jan; 30(1):60-6. PubMed ID: 20847676
    [Abstract] [Full Text] [Related]

  • 2. Recurrence of corneal neovascularization associated with lipid deposition after subconjunctival injection of bevacizumab.
    Chu HS, Chen TC, Hu FR, Chen WL.
    Cornea; 2013 Nov; 32(11):1446-53. PubMed ID: 24055900
    [Abstract] [Full Text] [Related]

  • 3. Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy.
    Oh JY, Kim MK, Wee WR.
    Cornea; 2009 Oct; 28(9):1070-3. PubMed ID: 19724199
    [Abstract] [Full Text] [Related]

  • 4. Combined use of superficial keratectomy and subconjunctival bevacizumab injection for corneal neovascularization.
    Qian CX, Bahar I, Levinger E, Rootman D.
    Cornea; 2008 Oct; 27(9):1090-2. PubMed ID: 18812781
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization.
    You IC, Kang IS, Lee SH, Yoon KC.
    Acta Ophthalmol; 2009 Sep; 87(6):653-8. PubMed ID: 19021596
    [Abstract] [Full Text] [Related]

  • 6. Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs.
    Koenig Y, Bock F, Kruse FE, Stock K, Cursiefen C.
    Cornea; 2012 Aug; 31(8):887-92. PubMed ID: 22362005
    [Abstract] [Full Text] [Related]

  • 7. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.
    Chen WL, Lin CT, Lin NT, Tu IH, Li JW, Chow LP, Liu KR, Hu FR.
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1659-65. PubMed ID: 18997093
    [Abstract] [Full Text] [Related]

  • 8. Subconjunctival bevacizumab injection for corneal neovascularization.
    Bahar I, Kaiserman I, McAllum P, Rootman D, Slomovic A.
    Cornea; 2008 Feb; 27(2):142-7. PubMed ID: 18216566
    [Abstract] [Full Text] [Related]

  • 9. The different effects of early and late bevacizumab (Avastin) injection on inhibiting corneal neovascularization and conjunctivalization in rabbit limbal insufficiency.
    Lin CT, Hu FR, Kuo KT, Chen YM, Chu HS, Lin YH, Chen WL.
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6277-85. PubMed ID: 20435600
    [Abstract] [Full Text] [Related]

  • 10. [Subconjunctival bevacizumab for corneal neovascularization].
    Gueudry J, Richez F, Tougeron-Brousseau B, Genevois O, Muraine M.
    J Fr Ophtalmol; 2010 Nov; 33(9):630-6. PubMed ID: 21035899
    [Abstract] [Full Text] [Related]

  • 11. Subconjunctival bevacizumab for corneal neovascularization.
    Zaki AA, Farid SF.
    Acta Ophthalmol; 2010 Dec; 88(8):868-71. PubMed ID: 19519730
    [Abstract] [Full Text] [Related]

  • 12. Subconjunctival bevacizumab for corneal neovascularization.
    Doctor PP, Bhat PV, Foster CS.
    Cornea; 2008 Oct; 27(9):992-5. PubMed ID: 18812760
    [Abstract] [Full Text] [Related]

  • 13. Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium.
    Bahar I, Kaiserman I, McAllum P, Rootman D, Slomovic A.
    Curr Eye Res; 2008 Jan; 33(1):23-8. PubMed ID: 18214740
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).
    Kim TI, Kim SW, Kim S, Kim T, Kim EK.
    Cornea; 2008 Apr; 27(3):349-52. PubMed ID: 18362666
    [Abstract] [Full Text] [Related]

  • 15. Combined use of subconjunctival and intracorneal bevacizumab injection for corneal neovascularization.
    Yeung SN, Lichtinger A, Kim P, Amiran MD, Slomovic AR.
    Cornea; 2011 Oct; 30(10):1110-4. PubMed ID: 21673570
    [Abstract] [Full Text] [Related]

  • 16. Photodynamic therapy with verteporfin combined with subconjunctival injection of bevacizumab for corneal neovascularization.
    You IC, Im SK, Lee SH, Yoon KC.
    Cornea; 2011 Jan; 30(1):30-3. PubMed ID: 20861729
    [Abstract] [Full Text] [Related]

  • 17. The effect of topical bevacizumab on corneal neovascularization.
    Kim SW, Ha BJ, Kim EK, Tchah H, Kim TI.
    Ophthalmology; 2008 Jun; 115(6):e33-8. PubMed ID: 18439681
    [Abstract] [Full Text] [Related]

  • 18. Perilimbal bevacizumab injection for interface neovascularization after deep anterior lamellar keratoplasty.
    Foroutan A, Fariba B, Pejman B, Mahmoud J, Khalil GF, Arash EA, Foroutan P.
    Cornea; 2010 Nov; 29(11):1268-72. PubMed ID: 20802316
    [Abstract] [Full Text] [Related]

  • 19. Effects of subconjunctival bevacizumab on corneal neovascularization: results of a prospective study.
    Benayoun Y, Adenis JP, Casse G, Forte R, Robert PY.
    Cornea; 2012 Aug; 31(8):937-44. PubMed ID: 22357391
    [Abstract] [Full Text] [Related]

  • 20. Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model.
    Avisar I, Weinberger D, Kremer I.
    Curr Eye Res; 2010 Feb; 35(2):108-15. PubMed ID: 20136420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.